Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Abbvie inc. crawled date : 2022 - 05 - 23 save search
AbbVie Presents Positive Data from Phase 3 Study of Cariprazine (VRAYLAR®) for the Adjunctive Treatment of Major Depressive Disorder at 2022 APA Annual Meeting
Published: 2022-05-23 (Crawled : 16:00) - biospace.com/
ABBV | $161.67 -0.38% -0.04% 5.4M
|
Health Technology
|
| O: -0.51%
H: 0.0%
C: 0.0%
vraylar treatment positive phase 3 major depressive disorder
Global $3.12 Billion Head and Neck Cancer Therapeutics Markets, Analysis, Opportunities and Forecasts, 2027
Published: 2022-05-23 (Crawled : 11:00) - prnewswire.com
SNYNF | $92.9 -2.18% 880
|
Health Technology
|
| O: -3.11%
H: 0.0%
C: 0.0%
AZNCF | $138.88 -4.19% 960
|
Health Technology
|
| O: 5.07%
H: 0.28%
C: -1.81%
ALPMY | $9.55 -1.11% 300K
|
Manufacturing
|
| O: 1.8%
H: 0.26%
C: -0.13%
TEVA | $13.23 -0.53% -0.23% 13M
|
Health Technology
|
| O: 0.94%
H: 0.93%
C: -1.29%
LLY | $750.77 -0.12% 0.0% 2.3M
|
Health Technology
|
| O: 3.76%
H: 0.0%
C: 0.0%
ABBV | $161.67 -0.38% -0.04% 5.4M
|
Health Technology
|
| O: -0.51%
H: 0.0%
C: 0.0%
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: 1.61%
H: 0.0%
C: 0.0%
AZN | $68.75 -0.26% -0.26% 7.6M
|
Health Technology
|
| O: 1.61%
H: 1.29%
C: -0.08%
therapeutics cancer
CHMP Recommends European Commission Approval of Upadacitinib (RINVOQ®) for the Treatment of Adults with Moderate to Severe Ulcerative Colitis
Published: 2022-05-23 (Crawled : 07:00) - prnewswire.com
ABBV | $161.67 -0.38% -0.04% 5.4M
|
Health Technology
|
| O: -0.51%
H: 0.0%
C: 0.0%
rinvoq treatment chmp approval ulcerative colitis
Gainers vs Losers
| 49% | 51% |
Top 10 Gainers
KAVL | $6.275 135.02% 57.45% 44M
|
Wholesale Trade
PXMD | $0.7375 79.09% 44.16% 4.5M
|
Health Technology
DYNT | $0.371 -5.12% 43.09% 3.3M
|
Health Technology
LGVN P 3 d | $2.94 73.96% 42.52% 57M
|
HUBC | $1.94 49.23% 32.99% 73M
|
n/a
SPCB | $0.4044 46.52% 31.75% 130M
|
Electronic Technology
ONVO | $1.34 32.66% 24.62% 54M
|
Health Technology
OMQS | $0.6869 32.1% 24.3% 3.6M
|
Professional, Scientific, and T...
SNPO | $10.555 29.67% 22.88% 4M
|
AMBI | $3.72 -26.77% 21.77% 9.8K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.